An in vitro caseum binding assay that predicts drug penetration in tuberculosis lesions

Journal of Visualized Experiments

Volumn 2017, Issue 123, 2017, Pages

  Sarathy, Jansy P ^a   Liang, Hsin Pin Ho ^a   Weiner, Danielle ^b   Gonzales, Jacqueline ^b   Via, Laura E ^b   Dartois, Véronique ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Caseum; Drug penetration; Granuloma; In vitro assay; Infection; Issue 123; Mycobacterium tuberculosis; Rapid equilibrium dialysis

Indexed keywords

TUBERCULOSTATIC AGENT;

ANIMAL; BIOASSAY; DRUG DEVELOPMENT; DRUG EFFECTS; IN VITRO STUDY; LEPORIDAE; LUNG; MACROPHAGE; METABOLISM; PATHOLOGY; PROCEDURES; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; BIOLOGICAL ASSAY; DRUG DISCOVERY; IN VITRO TECHNIQUES; LUNG; MACROPHAGES; RABBITS; TUBERCULOSIS;

EID: 85018879059     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/55559     Document Type: Article

References (17)

1. Sacchettini, J. C., Rubin, E. J., and Freundlich, J. S. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Nat Rev Microbiol. 6(1), 41-52 (2008).
2. Zhang, Y. Persistent and dormant tubercle bacilli and latent tuberculosis. Front Biosci. 1(9), 1136-1156 (2004).
3. Aber, V. R. and Nunn, A. J. Short term chemotherapy of tuberculosis. Factors affecting relapse following short term chemotherapy. Bull Int Union Tuberc. 53(4), 276-280, (1978).
4. Chang, K. C., Leung, C. C., Yew, W. W., Ho, S. C., and Tam, C. M. A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med. 170(10), 1124-1130 (2004).
5. Dartois, V. The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nature Rev Microbiol. 12(3), 159-167 (2014).
6. Prideaux, B. et al. The association between sterilizing activity and drug distribution into tuberculosis lesions. Nat Med. 21(10), 1223-1227 (2015).
7. Sarathy, J. P. et al. Prediction of Drug Penetration in Tuberculosis Lesions. ACS Infect Dis. 2(8), 552-563 (2016).
8. Waters, N. J., Jones, R., Williams, G., and Sohal, B. Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. J Pharm Sci. 97(10), 4586-4595 (2008).
9. Singh, J. K., Solanki, A., Maniyar, R. C., Banerjee, D., and Shirsath, V. S. Rapid Equilibrium Dialysis (RED): an In-vitro High-Throughput Screening Technique for Plasma Protein Binding using Human and Rat Plasma. J Bioequiv Availab. (S14), 1-4 (2012).
10. Liu, X. et al. Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid. Drug Metab Dispos. 37(4), 787-793 (2009).
11. Able, S. L. et al. Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat. Br J Pharmacol. 162(2), 405-414 (2011).
12. Subbian, S. et al. Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response. Open Biol. 1(4), 1-14 (2011).
13. Via, L. E. et al. Tuberculous Granulomas are Hypoxic in Guinea pigs, Rabbits, and Non-Human Primates. Infect Immun. 76(6), 2333-2340 (2008).
14. Kalvass, J. C. and Maurer, T. S. Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery. Biopharm Drug Dispos. 23(8), 327-338 (2002).
15. Di, L., Umland, J. P., Trapa, P. E., and Maurer, T. S. Impact of recovery on fraction unbound using equilibrium dialysis. J Pharm Sci. 101(3), 1327-1335 (2012).
16. Lenaerts, A. J. et al. Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910. Antimicrob Agents Chemother. 51(9), 3338-3345 (2007).
17. Prideaux, B. et al. High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions. Anal Chem. 83(6), 2112-2118 (2011).